Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics ...
Source: businessinsider.com